MétaCan
Menu
Back to cohort
Record W4391771543 · doi:10.1101/2024.02.13.24302744

The LYMPH Trial - Comparing Microsurgical with Conservative Treatment of Chronic Breast Cancer Associated Lymphedema: Study Protocol of a Pragmatic Randomized International Multicentre Superiority Trial

2024· preprint· en· W4391771543 on OpenAlexaff
Elisabeth A. Kappos, Yvonne Haas, Alexandra Schulz, Florian Peters, Shakuntala Savanthrapadian, Julia Stoffel, Maria C. Katapodi, Rosine Mucklow, Benedict Kaiser, Alexander Haumer, Stephanie J. Etter, Marco Cattaneo, Daniel Staub, Karin Ribi, Jane Shaw, Tristan M Handschin, Steffen U. Eisenhardt, Giuseppe Visconti, Gianluca Franceschini, Lorenzo Scardina, Benedetto Longo, Marcus Vetter, Khalil Zaman, Jan A. Plock, Mario F. Scaglioni, Eduardo González, Sergio Quildrian, Gunther Felmerer, Babak J. Mehrara, Jaume Masià, Gemma Pons, Daniel F. Kalbermatten, Justin M. Sacks, Martin Halle, Maximillian V Muntean, Erin M. Taylor, Maria Mani, Florian Jung, Pietro G. di Summa, Efterpi Demiri, Dimitrios Dionyssiou, Anne Karoline Groth, Norbert Heine, Joshua Vorstenborsch, Kathryn V. Isaac, Shan Shan Qiu, Patricia E. Engels, Axelle Serre, Anna-Lena Eberhardt, Matthias Schwenkglenks, Yvette Stoel, Cornelia Leo, Raymund E. Horch, Phillip Blondeel, Björn Behr, Ulrich Kneser, Lukas Prantl, Daniel T. Boll, Cristina Granziera, Lars G. Hemkens, Nicole Lindenblatt, Martin Haug, Dirk J. Schaefer, Christoph Hirche, Andrea L. Pusic, K Seidenstücker, Yves Harder, William P. Weber

Bibliographic record

VenuemedRxiv · 2024
Typepreprint
Languageen
FieldMedicine
TopicLymphatic System and Diseases
Canadian institutionsUniversity of British ColumbiaMcGill University
FundersSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
KeywordsMedicineLymphedemaRandomized controlled trialBreast cancerRandomizationQuality of life (healthcare)Clinical endpointPhysical therapySurgeryCancerInternal medicine

Abstract

fetched live from OpenAlex

ABSTRACT Introduction Up to one fifth of breast cancer survivors will develop chronic breast cancer-related lymphedema (BCRL). To date complex physical decongestion therapy (CDT) is the gold standard of treatment. However, it is mainly symptomatic and often ineffective in preventing BCRL progression. Lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) are microsurgical techniques that aim to restore lymphatic drainage. This international randomized trial aims to evaluate advantages of microsurgical interventions plus CDT vs CDT alone for BCRL treatment. Methods and analysis The effectiveness of LVA and/or VLNT in combination with CDT, which may be combined with liposuction, versus CDT alone will be evaluated in routine practice across the globe. BCRL patients will be randomly allocated to either surgical or conservative therapy. The primary endpoint of this trial is the patient-reported quality of life (QoL) outcome “lymphedema-specific QoL”, which will be assessed 15 months after randomization. Secondary endpoints are further patient reported outcomes (PROs), arm volume measurements, economic evaluations, and imaging at different timepoints. A long-term follow-up will be conducted up to 10 years after randomization. A total of 280 patients will be recruited in over 20 sites worldwide. Ethics and dissemination This study will be conducted in compliance with the Declaration of Helsinki and the ICH-GCP E6 guideline. Ethical approval has been obtained by the lead Ethics Committee ‘Ethikkommission Nordwest- und Zentralschweiz‘ (2023–00733, 22.05.2023). Ethical approval from local authorities will be sought for all participating sites. Regardless of outcomes, the findings will be published in a peer-reviewed medical journal. Metadata detailing the dataset’s type, size and content will be made available, along with the full study protocol and case report forms, in public repositories in compliance with the FAIR principles. Trial registration The trial is registered at https://clinicaltrials.gov (ID: NCT05890677 ) and on the Swiss National Clinical Trials Portal (SNCTP, BASEC project-ID: 2023-00733) at https://kofam.ch/de . The date of first registration was 23.05.2023. Strengths and limitations of this study - This is a pragmatic, randomized, international, multicentre, superiority trial, which has the potential to impact the clinical practice of therapy for patients with chronic BCRL. - The pragmatic design will reflect clinical practice, thereby directly providing applicable results. - A comprehensive long-term follow-up will be conducted, extending up to 10 years, to assess and analyze long-term outcomes. - Patient advocates were intensely involved throughout the trial design. - To date, no multicentric RCT has compared microsurgical techniques (LVA and VLNT) possibly combined with liposuction with CDT alone, thereby limiting patient’s access to available treatment options. - The assessment of treatment quality (both conservative and surgical) at various sites is challenging due to potential variations resulting from the pragmatic design, which may influence the study’s outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.119
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.358
Teacher spread0.326 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes1
Has abstractyes

Explore more

Same venuemedRxivSame topicLymphatic System and DiseasesFrench-language works237,207